| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014638817 |
| P356 | DOI | 10.1245/S10434-014-3890-4 |
| P698 | PubMed publication ID | 25012264 |
| P2093 | author name string | Rebecca A Nelson | |
| Thehang Luu | |||
| Lily L Lai | |||
| Mary L Guye | |||
| P2860 | cites work | Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis | Q25257542 |
| ERBB receptors and cancer: the complexity of targeted inhibitors | Q29619520 | ||
| Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base | Q31070408 | ||
| Metaplastic breast cancer: to radiate or not to radiate? | Q34477295 | ||
| Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature | Q36606990 | ||
| Basal carcinoma of the breast revisited: an old entity with new interpretations. | Q37104342 | ||
| Metaplastic breast carcinoma: a case report and systematic review of the literature | Q37939434 | ||
| Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis | Q38360532 | ||
| Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma | Q42503707 | ||
| The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes | Q42511189 | ||
| Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer | Q43167779 | ||
| Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer | Q46771645 | ||
| Metaplastic carcinoma of the breast. | Q53335453 | ||
| The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. | Q53677254 | ||
| Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. | Q54597304 | ||
| The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients. | Q54615889 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 24-31 | |
| P577 | publication date | 2014-07-11 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis | |
| P478 | volume | 22 |
| Q34958151 | An 18-year-old woman with a 34-cm metaplastic breast carcinoma. |
| Q92640014 | Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study |
| Q38431284 | Clinical management of breast cancer heterogeneity |
| Q64101482 | Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast |
| Q35675665 | Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center |
| Q41144888 | Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast |
| Q42243444 | Dramatic response of metaplastic breast cancer to chemo-immunotherapy |
| Q48251979 | Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014. |
| Q38849143 | Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases. |
| Q40061357 | Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma |
| Q55234434 | Management of the axilla in metaplastic breast carcinoma. |
| Q88946200 | Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database |
| Q48265396 | Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy |
| Q37624202 | Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment |
| Q42045424 | Metaplastic Breast Carcinoma: Analysis of Clinical and Pathologic Characteristics - A Case Series |
| Q35121897 | Metaplastic breast cancer: a comparison between the most common histologies with poor immunohistochemistry factors |
| Q99557525 | Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1 |
| Q38687963 | Predictive factors on outcomes in metaplastic breast cancer. |
| Q90610564 | Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation |
| Q93048401 | The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database |
| Q52733226 | The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas. |
| Q36146505 | The Present and Future Opportunities of the Rare Cancer Network: An International Consortium for Advancement of Oncologic Care |
| Q104486602 | The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma |
| Q90235755 | The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database |
| Q38563866 | Treatment and Prognosis of Rare Breast Cancers. |
| Q64986730 | Treatment choice in metaplastic breast cancer: A report of 5 cases. |
| Q50910046 | Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component. |
Search more.